Psychedelic Spotlight
2021-11-26

New Paul Stamets Psychedelic Microdosing Study with MindMed and Numi Connections | New DMT Study

Substance Abuse

Anxiety

Stress

In this episode of the $Psyc Business Roundup, we’ll cover Algernon Pharmaceuticals (OTC: AGNPF, CSE: AGN) is planning to begin a clinical trial using DMT to treat acute strokes.

Related News